Sanjiv M Narayan, MD
Cardiac Electrophysiology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 6
- 3 carriers
- Offices
- 2
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
6 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Narayan’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
6 of 6 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A56441 · Current
Licensed to practise in California · since 1996 · expires 2028-04-30 · University of Birmingham Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$26,334
Medicare paid this office $26,334 for 443 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 28 | $5,200 | $168 |
| New patient visit (60+ min) | 17 | $3,546 | $209 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 338 | $2,711 | $7 |
| Return visit (30+ min) | 14 | $1,732 | $124 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 29 | $615 | $21 |
Procedures Medicare counted
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
443 Original Medicare patients in 2024. Average age 75 · Under 65 9% · 85 and older 19% · Women 54% · Also on Medicaid 27% · Health risk score 2.25. Sicker patients than 9 in 10 peers; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 75% · Atrial fibrillation 50% · Coronary heart disease 48% · Chronic kidney disease 41% · Heart failure 39% · Diabetes 37% · Cancer 26% · Depression 26% · COPD 21% · Stroke 20% · Dementia 19%.
The office billed $191,514, Medicare allowed $33,174 and paid $26,334; for 539 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 443 | 539 | 75 | 2.25 | $191,514 | $26,334 |
| 2023 | 145 | 231 | 77 | 2.02 | $180,067 | $23,273 |
| 2022 | 651 | 1,041 | 75 | 2.13 | $446,954 | $62,824 |
| 2021 | 426 | 774 | 75 | 2.15 | $479,948 | $65,849 |
| 2020 | 315 | 599 | 74 | 1.93 | $266,216 | $42,384 |
| 2019 | 429 | 780 | 74 | 1.98 | $301,931 | $58,772 |
| 2018 | 383 | 717 | 74 | 1.92 | $319,868 | $62,935 |
| 2017 | 329 | 612 | 73 | 1.94 | $253,945 | $51,485 |
| 2016 | 286 | 549 | 74 | 1.76 | $397,797 | $64,947 |
| 2015 | 125 | 292 | 73 | 1.59 | $235,327 | $44,365 |
| 2014 | 36 | 78 | 72 | 1.23 | $49,660 | $10,206 |
| 2013 | 39 | 99 | 77 | 1.52 | $26,072 | $4,722 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Long return visit (40+ min) | 68 | $8,953 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $3,137 | $71 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 19 | $537 | $27 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 15 | $374 | $23 |
| Programming of dual lead pacemaker system | 11 | $305 | $28 |
2022: 12 services
| Long return visit (40+ min) | 75 | $12,070 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 63 | $6,618 | $63 |
| New patient visit (60+ min) | 38 | $5,726 | $151 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 351 | $3,042 | $7 |
| Return visit (30+ min) | 40 | $2,983 | $71 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 23 | $2,170 | $90 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $2,059 | $121 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 75 | $1,778 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 35 | $1,594 | $27 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,387 | $92 |
| Programming of dual lead pacemaker system | 19 | $834 | $33 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 11 | $245 | $22 |
2021: 14 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 15 | $14,837 | $989 |
| New patient visit (60+ min) | 40 | $6,433 | $161 |
| Return visit (30+ min) | 58 | $6,148 | $87 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 20 | $5,223 | $261 |
| Long return visit (40+ min) | 22 | $2,780 | $121 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,699 | $64 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 20 | $2,290 | $115 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 206 | $1,789 | $7 |
| Short return visit (20+ min) | 31 | $1,646 | $48 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,519 | $127 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 51 | $1,279 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 34 | $1,138 | $21 |
| Programming of dual lead pacemaker system | 16 | $570 | $30 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 11 | $274 | $23 |
2020: 11 services
| Return visit (30+ min) | 38 | $2,616 | $64 |
| New patient visit (60+ min) | 17 | $2,580 | $152 |
| Short return visit (20+ min) | 45 | $2,095 | $37 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,036 | $66 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,775 | $93 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 35 | $1,648 | $26 |
| Long return visit (40+ min) | 13 | $1,231 | $95 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 102 | $975 | $8 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 31 | $914 | $23 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 13 | $568 | $32 |
| Programming of dual lead pacemaker system | 19 | $391 | $19 |
2019: 14 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 11 | $11,862 | $988 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 12 | $3,652 | $261 |
| Long return visit (40+ min) | 29 | $3,084 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $2,534 | $65 |
| Return visit (30+ min) | 35 | $2,439 | $66 |
| Short return visit (20+ min) | 50 | $2,368 | $45 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 255 | $2,313 | $8 |
| New patient visit (60+ min) | 16 | $2,142 | $134 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 13 | $2,002 | $133 |
| Programming of dual lead pacemaker system | 31 | $1,734 | $35 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,635 | $91 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 17 | $722 | $26 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 17 | $675 | $36 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 18 | $539 | $25 |
2018: 14 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 13 | $12,664 | $974 |
| Long return visit (40+ min) | 51 | $5,733 | $97 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 13 | $4,793 | $369 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 14 | $3,996 | $285 |
| Return visit (30+ min) | 37 | $3,352 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $3,203 | $65 |
| New patient visit (60+ min) | 17 | $2,346 | $138 |
| Programming of dual lead pacemaker system | 26 | $1,935 | $34 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 224 | $1,920 | $8 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 14 | $1,845 | $132 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,257 | $90 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $490 | $35 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 11 | $414 | $24 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 11 | $270 | $25 |
2017: 10 services
| New patient visit (60+ min) | 53 | $7,508 | $142 |
| Return visit (30+ min) | 42 | $4,056 | $64 |
| Long return visit (40+ min) | 20 | $1,874 | $94 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 170 | $1,533 | $8 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,464 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,296 | $65 |
| Programming of dual lead pacemaker system | 18 | $1,256 | $34 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $1,083 | $35 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $987 | $90 |
| Short return visit (20+ min) | 18 | $822 | $41 |
2016: 11 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 16 | $17,179 | $954 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 17 | $6,047 | $336 |
| New patient visit (60+ min) | 44 | $5,600 | $127 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 13 | $4,653 | $358 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 20 | $2,807 | $128 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $2,079 | $63 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 32 | $1,914 | $34 |
| Return visit (30+ min) | 20 | $1,853 | $69 |
| Short return visit (20+ min) | 25 | $1,608 | $41 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,312 | $87 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 138 | $1,159 | $7 |
2015: 8 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 11 | $10,741 | $976 |
| New patient visit (60+ min) | 40 | $5,431 | $136 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 11 | $3,760 | $342 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,265 | $65 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 12 | $1,574 | $131 |
| Short return visit (20+ min) | 22 | $1,560 | $43 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,116 | $93 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $974 | $35 |
2014: 1 service
| Short return visit (20+ min) | 11 | $500 | $38 |
2013: 2 services
| Short return visit (20+ min) | 19 | $1,032 | $36 |
| Return visit (30+ min) | 11 | $683 | $53 |
Medicaid work
$2,228 in 2024
Medicaid paid $2,228 for 261 billed services this clinician did in 2024, up to 129 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 261 | $2,228 |
| 2024 | 261 | 1 | 129 | $2,228 |
| 2022 | 397 | 1 | 231 | $3,586 |
| 2021 | 220 | 1 | 118 | $2,053 |
| 2020 | 110 | 1 | 96 | $1,022 |
| 2019 | 174 | 1 | 152 | $1,580 |
| 2018 | 135 | 1 | 75 | $1,309 |
See the largest Medicaid services in earlier years
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 397 | $3,586 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 220 | $2,053 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 110 | $1,022 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 174 | $1,580 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 135 | $1,309 |
Drugs they prescribed that Part D paid
$85,196
Pharmacies billed $85,196 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 138) in 2024. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 0%.
76 generic and 62 brand-name prescriptions · $85,196 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 38 | $48,409 | $1,274 |
| Xarelto | 12 | $16,826 | $1,402 |
| Multaq | 11 | $15,653 | $1,423 |
| Dofetilide | 18 | $2,453 | $136 |
Year by year
| 2024 | 138 | 46 | 0% (0) | 45% | $85,196 |
| 2023 | 354 | 74 | 0% (0) | 41% | $221,198 |
| 2022 | 410 | 95 | 0% (0) | 40% | $226,026 |
| 2021 | 425 | 80 | 0% (0) | 42% | $196,994 |
| 2020 | 329 | 67 | 0% (0) | 41% | $152,044 |
| 2019 | 454 | 76 | 0% (0) | 43% | $182,926 |
| 2018 | 522 | 88 | 0% (0) | 42% | $152,008 |
| 2017 | 365 | 53 | 0% (0) | 42% | $90,005 |
| 2016 | 254 | 42 | None | 49% | $60,783 |
| 2015 | 144 | 33 | None | 38% | $18,300 |
| 2014 | 32 | None | 0% (0) | 56% | $3,341 |
| 2013 | 17 | None | 0% (0) | None | $2,045 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Eliquis | 91 | $132,657 | $1,458 |
| Xarelto | 27 | $33,832 | $1,253 |
| Multaq | 19 | $22,993 | $1,210 |
| Dofetilide | 48 | $19,965 | $416 |
| Amiodarone | 28 | $2,128 | $76 |
| Flecainide Acetate | 18 | $1,568 | $87 |
| Enoxaparin | 12 | $635 | $53 |
| Metoprolol | 11 | $219 | $20 |
| Sotalol | 12 | $174 | $14 |
2022: 12 drugs
| Eliquis | 77 | $113,671 | $1,476 |
| Xarelto | 46 | $56,752 | $1,234 |
| Dofetilide | 52 | $21,760 | $418 |
| Multaq | 18 | $16,256 | $903 |
| Flecainide Acetate | 16 | $2,016 | $126 |
| Enoxaparin | 23 | $1,531 | $67 |
| Amiodarone | 33 | $1,437 | $44 |
| Diltiazem 24hr Er (Cd) | 11 | $653 | $59 |
| Metoprolol | 32 | $578 | $18 |
| Sucralfate | 15 | $345 | $23 |
| Pantoprazole | 14 | $106 | $8 |
| Metoprolol | 12 | $95 | $8 |
2021: 9 drugs
| Eliquis | 73 | $97,346 | $1,334 |
| Xarelto | 61 | $46,588 | $764 |
| Dofetilide | 53 | $21,009 | $396 |
| Flecainide Acetate | 23 | $1,857 | $81 |
| Enoxaparin | 26 | $1,619 | $62 |
| Amiodarone | 42 | $1,292 | $31 |
| Sucralfate | 19 | $983 | $52 |
| Metoprolol | 26 | $366 | $14 |
| Pantoprazole | 16 | $132 | $8 |
2020: 6 drugs
| Eliquis | 46 | $58,990 | $1,282 |
| Xarelto | 46 | $37,053 | $805 |
| Dofetilide | 67 | $31,753 | $474 |
| Flecainide Acetate | 16 | $1,840 | $115 |
| Amiodarone | 32 | $1,668 | $52 |
| Metoprolol | 18 | $130 | $7 |
2019: 13 drugs
| Dofetilide | 93 | $49,822 | $536 |
| Eliquis | 59 | $48,357 | $820 |
| Xarelto | 53 | $40,007 | $755 |
| Multaq | 19 | $18,815 | $990 |
| Tikosyn | 13 | $7,949 | $611 |
| Flecainide Acetate | 18 | $1,490 | $83 |
| Enoxaparin | 16 | $1,005 | $63 |
| Amiodarone | 19 | $1,001 | $53 |
| Metoprolol | 27 | $779 | $29 |
| Sucralfate | 14 | $509 | $36 |
| Carvedilol | 17 | $241 | $14 |
| Metoprolol | 22 | $178 | $8 |
| Pantoprazole | 18 | $168 | $9 |
2018: 14 drugs
| Eliquis | 87 | $48,356 | $556 |
| Dofetilide | 110 | $43,953 | $400 |
| Xarelto | 38 | $24,012 | $632 |
| Multaq | 26 | $17,656 | $679 |
| Tikosyn | 13 | $8,058 | $620 |
| Enoxaparin | 19 | $1,460 | $77 |
| Flecainide Acetate | 38 | $1,460 | $38 |
| Sucralfate | 16 | $601 | $38 |
| Metoprolol | 16 | $567 | $35 |
| Amiodarone | 11 | $211 | $19 |
| Metoprolol | 26 | $158 | $6 |
| Pantoprazole | 16 | $146 | $9 |
| Carvedilol | 17 | $50 | $3 |
| Lisinopril | 13 | $35 | $3 |
2017: 10 drugs
| Dofetilide | 69 | $29,646 | $430 |
| Eliquis | 55 | $24,937 | $453 |
| Xarelto | 39 | $16,773 | $430 |
| Tikosyn | 13 | $7,042 | $542 |
| Enoxaparin | 18 | $1,447 | $80 |
| Flecainide Acetate | 23 | $727 | $32 |
| Metoprolol | 27 | $529 | $20 |
| Amiodarone | 16 | $325 | $20 |
| Propranolol | 12 | $264 | $22 |
| Metoprolol | 19 | $85 | $4 |
2016: 9 drugs
| Tikosyn | 32 | $20,521 | $641 |
| Eliquis | 42 | $17,287 | $412 |
| Multaq | 13 | $7,275 | $560 |
| Dofetilide | 13 | $6,225 | $479 |
| Enoxaparin | 21 | $3,000 | $143 |
| Sucralfate | 21 | $757 | $36 |
| Flecainide Acetate | 13 | $602 | $46 |
| Metoprolol | 19 | $351 | $18 |
| Pantoprazole | 17 | $154 | $9 |
2015: 4 drugs
| Tikosyn | 17 | $6,695 | $394 |
| Eliquis | 16 | $5,597 | $350 |
| Xarelto | 11 | $3,161 | $287 |
| Amiodarone | 11 | $177 | $16 |
Money from drug and device companies
$3,855 in 2025
| 2025 | 1 | 3 | $3,750 | $3,855 |
| 2024 | 1 | 1 | None | $80 |
| 2023 | 2 | 3 | $9,125 | $14,898 |
| 2021 | 2 | 2 | None | $190,504 |
| 2020 | 1 | 1 | $65,242 | $65,242 |
| 2019 | 3 | 7 | $81,516 | $82,167 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biotronik | Acticor 7 Vr-T Dx | $3,855 | 3 payments
|
See all 3 published payments
| Biotronik | Paid to speak or teach · 2025-12-29 | None | $3,750 |
| Biotronik | Meals · 2025-12-17 | Acticor 7 Vr-T Dx | $94 |
| Biotronik | Travel · 2025-12-17 | Acticor 7 Vr-T Dx | $11 |
See earlier years (2024, 2023, 2021, 2020, 2019)
2024: $80
| Medtronic | Linq II | $80 | 1 payment
|
2023: $14,898
| Medical Device Business Services | Carto 3 | $14,850 | 2 payments
|
| Abbott Laboratories | Aveir | $48 | 1 payment
|
2021: $190,504
| Topera | None | $190,400 | 1 payment
|
| Aziyo Biologics | Ecm Patch,Pouch | $104 | 1 payment
|
2020: $65,242
| Topera | None | $65,242 | 1 payment
|
2019: $82,167
| Topera | None | $81,516 | 1 payment
|
| Abbott Laboratories | Rhythmview Work Stations | $524 | 5 payments
|
| Biosense Webster | Carto 3 System | $127 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1649215492
- Licence
- CA A56441California A56441: Current · expires 2028-04-30
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A564410
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Cardiology (207RC0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-06-17
- NPI last updated
- 2024-04-24
- NPI record certified
- 2024-04-24
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 200 W Arbor Dr, San Diego, CA, 92103